IMX
IMX, licence 80008089: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80008089
- Status
- Active licence
- Licence date
- 16 October 2008
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 24 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Glycyrrhiza glabra L.: La portion journalière recommandée ne doit pas conduire à une ingestion d'acide glycyrrhizinique supérieure à 100 mg. L'étiquetage doit comporter un avertissement avec la teneur suivante: "Ne pas utiliser pendant plus de 6 semaines sans avis médical." L'étiquetage doit comporter un avertissement déconseillant l'emploi chez les enfants.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Riz | 4.0 mg | 24,000 µg |
| Zinc Source : HVP chelate from oryzae sativa | 4.0 mg | 24,000 µg |
| Vitamine A Source : Palmitate de vitamine A | 275.0 µg RAE | Not calculated |
| Mahonia aquifolia Source : Racine Extraction ratio : 4:1 Dry plant equivalent : 120 mg | 30.0 mg | Not calculated |
| Hydrastis canadensis Source : Racine | 20.0 mg | Not calculated |
| Bromélaïne Source : Tige(s) Potency : 3600.0 mcu/g | 30.0 mg | Not calculated |
| Glycyrrhiza glabra Source : Racine | 40.0 mg | Not calculated |
Non-medicinal ingredients
Silice, Hydroxy methyl cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Contains vitamins and minerals to promote and maintain good health and antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a healthcare practitioner prior to use if you have blood pressure problems, a kidney disorder, a liver disorder, a progressive systemic disease such as tuberculosis, leucosis, collagenosis, multiple sclerosis, AIDS and/or HIV infection, an autoimmune disorder. Consumption with alcohol, other medications and/or natural health products with sedative properties is not recommended.
- Contre-indications
Do not use if you are pregnant or breastfeeding, if you have hypokalemia, high blood pressure, a cardiovascular disorder, or if you are taking thiazide diuretics, cardiac glycosides, corticosteroids, stimulant laxatives or other medications which may aggravate electrolyte imbalance. Consult a healthcare practitioner prior to use if you are taking immunosuppressants.
Source
Official Health Canada record, licence 80008089
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
Has the product changed? Photograph the packaging.